Mizuho Medy Co., Ltd.

Mizuho Medy Co., Ltd. researches, develops, manufactures, and sells in vitro diagnostic products and provides related scientific and technical information services in Japan. Its offerings include molecular diagnostic products such as nucleic acid amplification test products, comprising gene analysis instruments and mycoplasma pneumoniae nucleic acid kits. The company also provides rapid immunoassay products, including antigen test kits for influenza virus, RS virus and human metapneumovirus, streptococcus pneumoniae and legionella, mycoplasma pneumoniae, adenovirus, rotavirus and adenovirus, norovirus, and Group A streptococcal antigen, as well as pregnancy, ovulation, and fecal occult blood test kits for in vitro diagnostic use. In addition, it offers reagents for detection in research and agriculture and reagents for biochemical tests, and engages in import and export activities. The company operates in the United States, Belgium, Finland, the Netherlands, Taiwan, Thailand, and internationally, and was incorporated in 1977 with headquarters in Tosu, Japan.